ASHLEY ADAMS: Open Payments
NPI 1942766258 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 34 payments from 14 companies in 2025. Trend: 2023 $808 · 2024 $794 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $146 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Amgen Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| ABBVIE INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $24 |
Products named: MOUNJARO, Cologuard Collection Kit, XIFAXAN, JARDIANCE, AIRSUPRA, EVENITY, KISUNLA, TEZSPIRE.
Industry payments across MO — which companies pay providers there.
